The effectiveness of nirmatrelvir therapy for preventing mortality and hospitalizations due to COVID-19 in high-risk patients during the Omicron surge - News-Medical.Net

Researchers evaluated how effective nirmatrelvir is in preventing COVID-19-associated death and hospitalization in high-risk patients.

In late 2021, there was a global resurgence of coronavirus disease 2019 (COVID-19) due to the emergence of the highly communicable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant… [+4177 chars]

full article...